Trial Profile
Pharmacokinetic Study of YM150 - A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Darexaban (Primary)
- Indications Acute coronary syndromes; Thromboembolism; Venous thrombosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 11 May 2010 New trial record